ASND — ASCENDIS PHARMA A/S

Ownership history in First Turn Management, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which First Turn Management, LLC reported a position in ASCENDIS PHARMA A/S (ASND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.37% (2025 Q3)
Avg. % of fund
3.5%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 131,808 -14,483 -9.9% 3.21% $28.1M $213.24
2025 Q3 ADDED 146,291 +11,604 +8.6% 4.37% $29.1M $198.81
2025 Q2 ADDED 134,687 +21,409 +18.9% 4.34% $23.2M $172.60
2025 Q1 ADDED 113,278 +25,474 +29.0% 3.56% $17.7M $155.86
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ASND price (monthly, adj. close)

Other funds also holding ASND

As of 2025 Q4 — sorted by position size

Q Global Advisors, LLC 3Y 7Y 39.86% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 22.46% Avoro Capital Advisors LLC 3Y 7Y 10.71% Resolute Capital Asset Partners LLC 3Y 9.13% Tri Locum Partners LP 3Y 7.34% WESTFIELD CAPITAL MANAGEMENT CO LP 3Y 7Y 4.61% Catalio Capital Management, LP 4.49% Spyglass Capital Management LLC 3Y 7Y 4.43% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.11% PFM Health Sciences, LP 3Y 7Y 3.78%
← Back to First Turn Management, LLC Holdings